The data displays the distribution of personalized medicine in different therapeutic areas in the U.S., as of October 2013. Some 38% of personalized treatments were in the oncology field. Personalized treatments are still lower in gastroenterology and rheumatology therapeutic areas with five and 4% respectively.
Hematology/oncology | 38 |
Psychiatry | 17 |
Infectious diseases | 10 |
Cardiology | 7 |
Endocrinology | 6 |
Neurolgy | 6 |
Gastroenterology | 5 |
Rheumatology | 4 |
Others | 7 |